JY Park, SJ You, K Park, YJ Song, JS Park… - Journal of Industrial and …, 2021 - Elsevier
Sorafenib (SF) is a standard, clinically-recognized therapy for treating hepatocellular
carcinoma (HCC) patients. However, as a multikinase inhibitor, SF causes a systemic side …